TABUTEAU HERRIOT

Director, Chief Executive Officer, 10% Owner · 1 filing · Latest: Jun 9, 2026

Axsome Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
AXSM	TABUTEAU HERRIOT	Director, Chief Executive Officer, 10% Owner	Jun 9, 2026	Sale	$241.01	49,670	$12.0M	7,229	Jun 9 9:17 PM
AXSM	TABUTEAU HERRIOT	Director, Chief Executive Officer, 10% Owner	Jun 9, 2026	Option Exercise	$4.95	49,670	$245.9K	56,899	Jun 9 9:17 PM